21
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Perinatal mortality associated with induction of labour versus expectant management in nulliparous women aged 35 years or over: An English national cohort study

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          A recent randomised controlled trial (RCT) demonstrated that induction of labour at 39 weeks of gestational age has no short-term adverse effect on the mother or infant among nulliparous women aged ≥35 years. However, the trial was underpowered to address the effect of routine induction of labour on the risk of perinatal death. We aimed to determine the association between induction of labour at ≥39 weeks and the risk of perinatal mortality among nulliparous women aged ≥35 years.

          Methods and findings

          We used English Hospital Episode Statistics (HES) data collected between April 2009 and March 2014 to compare perinatal mortality between induction of labour at 39, 40, and 41 weeks of gestation and expectant management (continuation of pregnancy to either spontaneous labour, induction of labour, or caesarean section at a later gestation). Analysis was by multivariable Poisson regression with adjustment for maternal characteristics and pregnancy-related conditions. Among the cohort of 77,327 nulliparous women aged 35 to 50 years delivering a singleton infant, 33.1% had labour induced: these women tended to be older and more likely to have medical complications of pregnancy, and the infants were more likely to be small for gestational age.

          Induction of labour at 40 weeks (compared with expectant management) was associated with a lower risk of in-hospital perinatal death (0.08% versus 0.26%; adjusted risk ratio [adjRR] 0.33; 95% CI 0.13–0.80, P = 0.015) and meconium aspiration syndrome (0.44% versus 0.86%; adjRR 0.52; 95% CI 0.35–0.78, P = 0.002). Induction at 40 weeks was also associated with a slightly increased risk of instrumental vaginal delivery (adjRR 1.06; 95% CI 1.01–1.11, P = 0.020) and emergency caesarean section (adjRR 1.05; 95% CI 1.01–1.09, P = 0.019). The number needed to treat (NNT) analysis indicated that 562 (95% CI 366–1,210) inductions of labour at 40 weeks would be required to prevent 1 perinatal death. Limitations of the study include the reliance on observational data in which gestational age is recorded in weeks rather than days. There is also the potential for unmeasured confounders and under-recording of induction of labour or perinatal death in the dataset.

          Conclusions

          Bringing forward the routine offer of induction of labour from the current recommendation of 41–42 weeks to 40 weeks of gestation in nulliparous women aged ≥35 years may reduce overall rates of perinatal death.

          Abstract

          In a cohort study using English Hospital Episode Statistics (HES) data, Hannah E Knight and colleagues examine perinatal mortality and other birth outcomes in association with labour induction at 39, 40, and 41 weeks.

          Author summary

          Why was this study done?
          • National guidelines recommend that induction of labour is carried out between 41 and 42 weeks of gestation to prevent the risks associated with prolonged pregnancy. However, women having their first baby at age 35 years or over are at increased risk of pregnancy complications, including perinatal death.

          • A recent randomised controlled trial demonstrated that induction of labour at 39 weeks of gestation has no short-term adverse effect on the mother or infant among nulliparous women aged 35 years or older. However, the trial was underpowered to address the effect of routine induction of labour on the risk of perinatal death.

          • The present study aims to answer the question ‘Does routine induction of labour at or after 39 weeks of gestation reduce the risk of perinatal mortality in first-time mothers aged 35 years or older, compared with expectant management?’

          What did the researchers do and find?
          • In this national cohort study of 77,327 first-time mothers aged 35 or older, induction of labour at 40 weeks of gestation was associated with a 66% lower risk of perinatal death (0.08% versus 0.26%) than expectant management.

          • Perinatal death is a rare outcome even in this group and 562 inductions of labour at 40 weeks would be required to prevent 1 perinatal death.

          What do these findings mean?
          • Bringing forward the routine offer of induction of labour from the current recommendation of 41–42 weeks to 40 weeks of gestation in this group of women may reduce overall rates of perinatal death.

          Related collections

          Most cited references14

          • Record: found
          • Abstract: not found
          • Article: not found

          Overestimation of risk ratios by odds ratios in trials and cohort studies: alternatives to logistic regression.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The risks associated with pregnancy in women aged 35 years or older.

            The obstetric risks of adverse outcome during pregnancy in women aged > or =35 years were quantified using a retrospective analysis of data from 385 120 singleton pregnancies in the North West Thames Region, UK, between 1988 and 1997. A comparison of pregnancy outcome was made on the basis of maternal age at delivery: 18-34 years (n = 336 462), 35-40 years (n = 41 327) and women aged > 40 years (n = 7331). Women aged 40 year old women, with adjusted odds ratios (OR) according to age group. Pregnant women aged 35-40 years were at increased risk of: gestational diabetes, OR = 2.63 [99% confidence interval (CI) 2.40-2.89]; placenta praevia = 1.93 (1.58-2.35); breech presentation = 1.37 (1.28-1.47); operative vaginal delivery = 1.5 (1.43-1.57); elective Caesarean section = 1.77 (1.68-1.87); emergency Caesarean section = 1.59 (1.52-1.67); postpartum haemorrhage = 1.14 (1.09-1.19); delivery before 32 weeks gestation = 1.41 (1.24-1.61); birthweight below the 5th centile = 1.28 (1.20-1. 36); and stillbirth = 1.41 (1.17-1.70). Women aged >40 years had higher OR for the same risks. Pregnant women aged >/=35 years are at increased risk of complications in pregnancy compared with younger women.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The perinatal effects of delayed childbearing.

              To determine if the rates of pregnancy complications, preterm birth, small for gestational age, perinatal mortality, and serious neonatal morbidity are higher among mothers aged 35-39 years or 40 years or older, compared with mothers 20-24 years. We performed a population-based study of all women in Nova Scotia, Canada, who delivered a singleton fetus between 1988 and 2002 (N = 157,445). Family income of women who delivered between 1988 and 1995 was obtained through a confidential linkage with tax records (n = 76,300). The primary outcome was perinatal death (excluding congenital anomalies) or serious neonatal morbidity. Analysis was based on logistic models. Older women were more likely to be married, affluent, weigh 70 kg or more, attend prenatal classes, and have a bad obstetric history but less likely to be nulliparous and to smoke. They were more likely to have hypertension, diabetes mellitus, placental abruption, or placenta previa. Preterm birth and small-for-gestational age rates were also higher; compared with women aged 20-24 years, adjusted rate ratios for preterm birth among women aged 35-39 years and 40 years or older were 1.61 (95% confidence interval [CI] 1.42-1.82; P < .001) and 1.80 (95% CI 1.37-2.36; P < .001), respectively. Adjusted rate ratios for perinatal mortality/morbidity were 1.46 (95% CI 1.11-1.92; P = .007) among women 35-39 years and 1.95 (95% CI 1.13-3.35; P = .02) among women 40 years or older. Perinatal mortality rates were low at all ages, especially in recent years. Older maternal age is associated with relatively higher risks of perinatal mortality/morbidity, although the absolute rate of such outcomes is low.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Formal analysisRole: MethodologyRole: Writing – original draftRole: Writing – review & editing
                Role: ConceptualizationRole: Formal analysisRole: Writing – review & editing
                Role: Formal analysisRole: Writing – review & editing
                Role: Formal analysisRole: MethodologyRole: Writing – review & editing
                Role: MethodologyRole: Writing – review & editing
                Role: ConceptualizationRole: Writing – review & editing
                Role: Academic Editor
                Journal
                PLoS Med
                PLoS Med
                plos
                plosmed
                PLoS Medicine
                Public Library of Science (San Francisco, CA USA )
                1549-1277
                1549-1676
                14 November 2017
                November 2017
                : 14
                : 11
                : e1002425
                Affiliations
                [1 ] Department of Health Services Research and Policy, London School of Hygiene & Tropical Medicine, London, United Kingdom
                [2 ] Royal College of Obstetricians and Gynaecologists, London, United Kingdom
                [3 ] Department of Obstetrics and Gynaecology, University of Cambridge, NIHR Cambridge Comprehensive Biomedical Research Centre, Cambridge, United Kingdom
                University of Manchester, UNITED KINGDOM
                Author notes

                We have read the journal's policy and the authors of this manuscript have the following competing interests: GCS is a member of the Editorial Board of PLOS Medicine. GCS receives/has received research support from GE (supply of 2 diagnostic ultrasound systems), from Roche (supply of equipment and reagents for biomarker studies, value £596,142), and from GSK (£199,413 for in vitro studies on human myometrium). GCS has been paid to attend advisory boards by GSK (preterm birth) and Roche (preeclampsia biomarkers). GCS has acted as a paid consultant to GSK (preterm birth). GCS has received support to attend a scientific meeting from Chiesi. GCS is a named inventor in a patent submitted by GSK for a novel application of an existing GSK compound for the prevention of preterm birth (PCT/EP2014/062602). GCS is a member of a GSK Data Safety Monitoring Committee for a trial of RSV vaccination in pregnancy and infancy.

                Author information
                http://orcid.org/0000-0002-6809-2517
                http://orcid.org/0000-0002-6516-8125
                http://orcid.org/0000-0002-3418-2856
                http://orcid.org/0000-0002-9451-2335
                http://orcid.org/0000-0003-2124-0997
                Article
                PMEDICINE-D-17-02346
                10.1371/journal.pmed.1002425
                5685438
                29136007
                f7d72627-cebc-4a04-82eb-8970c84a0ba9
                © 2017 Knight et al

                This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

                History
                : 4 July 2017
                : 3 October 2017
                Page count
                Figures: 3, Tables: 2, Pages: 14
                Funding
                The authors received no specific funding for this work.
                Categories
                Research Article
                Medicine and Health Sciences
                Women's Health
                Maternal Health
                Birth
                Labor and Delivery
                Medicine and Health Sciences
                Women's Health
                Obstetrics and Gynecology
                Birth
                Labor and Delivery
                Biology and Life Sciences
                Population Biology
                Population Metrics
                Death Rates
                Medicine and Health Sciences
                Women's Health
                Obstetrics and Gynecology
                Stillbirths
                Medicine and Health Sciences
                Women's Health
                Maternal Health
                Pregnancy
                Medicine and Health Sciences
                Women's Health
                Obstetrics and Gynecology
                Pregnancy
                Medicine and Health Sciences
                Women's Health
                Maternal Health
                Birth
                Medicine and Health Sciences
                Women's Health
                Obstetrics and Gynecology
                Birth
                Medicine and Health Sciences
                Vascular Medicine
                Blood Pressure
                Hypertension
                Hypertensive Disorders in Pregnancy
                Medicine and Health Sciences
                Women's Health
                Maternal Health
                Pregnancy
                Hypertensive Disorders in Pregnancy
                Medicine and Health Sciences
                Women's Health
                Obstetrics and Gynecology
                Pregnancy
                Hypertensive Disorders in Pregnancy
                Biology and Life Sciences
                Developmental Biology
                Neonates
                Medicine and Health Sciences
                Health Care
                Socioeconomic Aspects of Health
                Medicine and Health Sciences
                Public and Occupational Health
                Socioeconomic Aspects of Health
                Custom metadata
                The data governance arrangements for the study do not allow us to redistribute HES data to other parties. Researchers interested in accessing HES data can apply for access through NHS Digital’s Data Access Request Service (DARS) https://dataaccessrequest.hscic.gov.uk/. This study made use of pseudonymised HES extracts of women who gave birth between April 2009 and March 2014.

                Medicine
                Medicine

                Comments

                Comment on this article